Position
Chief Executive Officer
Company
XyloCor Therapeutics
Description
XyloCor Therapeutics has announced the appointment of John Tucker as President and Chief Executive Officer, effective immediately. Tucker brings over 20 years of experience in the biotechnology sector and aims to lead the company in accelerating its clinical programs.
Quick answer
XyloCor Appoints John Tucker as Chief Executive Officer (March 5, 2026).
- Who is the new Chief Executive Officer at XyloCor Therapeutics?
- XyloCor Therapeutics named John Tucker Chief Executive Officer, announced March 5, 2026.
- What did XyloCor Therapeutics announce on March 5, 2026?
- XyloCor Therapeutics has announced the appointment of John Tucker as President and Chief Executive Officer, effective immediately. Tucker brings over 20 years of experience in the biotechnology sector and aims to lead the company in accelerating its clinical programs.
- What does XyloCor Therapeutics do?
- XyloCor Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative gene therapies for cardiovascular diseases.
- Which similar companies made leadership changes around the same time?
- Lakefront Biotherapeutics NV (March 6, 2026), Royalty Pharma plc (March 3, 2026), AEON Biopharma (March 9, 2026) and Santhera Pharmaceuticals (March 10, 2026) also announced leadership changes within 45 days of XyloCor Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Galapagos NV Appoints Tania Philipp as Chief Human Resources Officer (March 6, 2026)
- Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia (March 3, 2026)
- AEON Biopharma Appoints John Bencich as Chief Financial Officer (March 9, 2026)
- Santhera Pharmaceuticals Appoints Marc Clausse as Chief Commercial Officer (March 10, 2026)
- MBX Biosciences Appoints Karen Basbaum as Chief Business Officer (March 10, 2026)
- IsomAb Ltd Appoints Dr. Philip Brainin as Chief Executive Officer (March 18, 2026)
Who to call at XyloCor Therapeutics, and when
A new leader at XyloCor Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day XyloCor Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at XyloCor Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at XyloCor Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment XyloCor Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
XyloCor Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.